It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used ...

The phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis did not meet the primary endpoint of a statistically significant improvement in time to treatment failure versus placebo as ...

XLRP is a severe, progressive inherited retinal disease that leads to blindness, typically by middle age, and currently has no approved treatments. It primarily affects young males, with an estimated ...

AEYE Health and UMass Memorial Health (UMMH) integrated AEYE Health's AEYE-DS, an AI-based autonomous diagnostic screening solution, into UMMH's EMR system. The goals of this integration are to ...

Tenpoint Therapeutics and Visus Therapeutics have merged to focus on aging-related ocular conditions, with key products including BRIMOCHOL PF for presbyopia and therapies for cataracts and geographic ...

The researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of diabetic macular edema (DME). The results of a recent study indicated ...

Aaron Nagial, MD, PhD, gave an interview discussing the work that he and the team at Children’s Hospital Los Angeles (CHLA) have been doing in the retinal gene therapy space. This interview comes at ...